JAMJOOM PHARMA

Jamjoom Pharmaceuticals Factory Co.

4015StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	9.94B	9.96B	10.65B	8.05B	—
Market Cap Growth	-11.1%	-6.5%	+32.3%	—	—
Enterprise Value	9.60B	9.80B	10.53B	7.95B	—
Last Close Price	142.00	140.17	146.85	108.69	—
Valuation Multiples
Forward PE (Next 12M Est.)	19.32	20.02	25.61	25.41	—
PE Ratio	21.43	21.48	29.88	27.53	—
PEG Ratio	—	1.43	1.60	1.02	—
PS Ratio	6.62	6.64	8.08	7.31	—
PB Ratio	5.79	5.80	7.15	5.73	—
P/TBV Ratio	5.85	5.86	7.20	5.79	—
P/FCF Ratio	28.14	28.20	51.60	32.11	—
P/OCF Ratio	24.47	24.52	40.46	27.20	—
EV/Sales Ratio	6.40	6.53	7.99	7.23	—
EV/EBITDA Ratio	18.03	18.94	24.82	23.28	—
EV/EBIT Ratio	19.63	20.62	27.16	25.19	—
EV/FCF Ratio	27.17	27.73	51.02	31.72	—
Leverage & Capital
Debt / Equity Ratio	0.01	0.01	0.00	0.00	0.00
Debt / EBITDA Ratio	0.03	0.03	0.00	0.01	0.01
Debt / FCF Ratio	0.05	0.05	0.01	0.01	0.02
Net Debt / Equity Ratio	-0.20	-0.20	-0.18	-0.21	-0.12
Net Debt / EBITDA Ratio	-0.66	-0.66	-0.62	-0.84	-0.54
Net Debt / FCF Ratio	-0.97	-0.97	-1.26	-1.15	-1.01
Efficiency & Liquidity
Asset Turnover	0.79	0.79	0.77	0.72	0.65
Inventory Turnover	2.18	2.18	1.98	2.18	2.44
Quick Ratio	4.36	4.36	3.65	3.58	4.16
Current Ratio	5.53	5.53	5.10	5.04	5.42
Returns & Yields
Return on Equity (ROE)	+28.9%	+28.9%	+24.6%	+22.3%	+14.0%
Return on Assets (ROA)	+15.6%	+15.6%	+14.2%	+12.9%	+10.7%
Return on Invested Capital (ROIC)	+31.2%	+34.3%	+30.8%	+26.7%	+20.7%
Return on Capital Employed (ROCE)	+26.1%	+26.1%	+24.7%	+21.4%	+18.9%
Earnings Yield	+4.7%	+4.7%	+3.3%	+3.6%	—
FCF Yield	+3.6%	+3.5%	+1.9%	+3.1%	—
Dividend Yield	+2.8%	+2.9%	+2.1%	+2.3%	—
Payout Ratio	+60.4%	+52.2%	+60.9%	+23.9%	+86.8%
Buyback Yield / Dilution	—	—	—	—	-600.0%
Total Shareholder Return	+2.8%	+2.9%	+2.1%	+2.3%	-600.0%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	9.94B	9.96B	10.65B	8.05B	—
Market Cap Growth	-11.1%	-6.5%	+32.3%	—	—
Enterprise Value	9.60B	9.80B	10.53B	7.95B	—
Last Close Price	142.00	140.17	146.85	108.69	—
Valuation Multiples
Forward PE (Next 12M Est.)	19.32	20.02	25.61	25.41	—
PE Ratio	21.43	21.48	29.88	27.53	—
PEG Ratio	—	1.43	1.60	1.02	—
PS Ratio	6.62	6.64	8.08	7.31	—
PB Ratio	5.79	5.80	7.15	5.73	—
P/TBV Ratio	5.85	5.86	7.20	5.79	—
P/FCF Ratio	28.14	28.20	51.60	32.11	—
P/OCF Ratio	24.47	24.52	40.46	27.20	—
EV/Sales Ratio	6.40	6.53	7.99	7.23	—
EV/EBITDA Ratio	18.03	18.94	24.82	23.28	—
EV/EBIT Ratio	19.63	20.62	27.16	25.19	—
EV/FCF Ratio	27.17	27.73	51.02	31.72	—
Leverage & Capital
Debt / Equity Ratio	0.01	0.01	0.00	0.00	0.00
Debt / EBITDA Ratio	0.03	0.03	0.00	0.01	0.01
Debt / FCF Ratio	0.05	0.05	0.01	0.01	0.02
Net Debt / Equity Ratio	-0.20	-0.20	-0.18	-0.21	-0.12
Net Debt / EBITDA Ratio	-0.66	-0.66	-0.62	-0.84	-0.54
Net Debt / FCF Ratio	-0.97	-0.97	-1.26	-1.15	-1.01
Efficiency & Liquidity
Asset Turnover	0.79	0.79	0.77	0.72	0.65
Inventory Turnover	2.18	2.18	1.98	2.18	2.44
Quick Ratio	4.36	4.36	3.65	3.58	4.16
Current Ratio	5.53	5.53	5.10	5.04	5.42
Returns & Yields
Return on Equity (ROE)	+28.9%	+28.9%	+24.6%	+22.3%	+14.0%
Return on Assets (ROA)	+15.6%	+15.6%	+14.2%	+12.9%	+10.7%
Return on Invested Capital (ROIC)	+31.2%	+34.3%	+30.8%	+26.7%	+20.7%
Return on Capital Employed (ROCE)	+26.1%	+26.1%	+24.7%	+21.4%	+18.9%
Earnings Yield	+4.7%	+4.7%	+3.3%	+3.6%	—
FCF Yield	+3.6%	+3.5%	+1.9%	+3.1%	—
Dividend Yield	+2.8%	+2.9%	+2.1%	+2.3%	—
Payout Ratio	+60.4%	+52.2%	+60.9%	+23.9%	+86.8%
Buyback Yield / Dilution	—	—	—	—	-600.0%
Total Shareholder Return	+2.8%	+2.9%	+2.1%	+2.3%	-600.0%